Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00071643
Status:
COMPLETED
Last Update Posted:
2017-09-05
First Post:
2003-10-29
Brief Title:
Preventing Post-Stroke Depression
Sponsor:
Robert G Robinson
Organization:
University of Iowa
Study Overview
Official Title:
Prevention of Post-Stroke Depression - Treatment Strategy
Status:
COMPLETED
Status Verified Date:
2017-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the effectiveness of both drug and non-drug treatments in preventing depression after a stroke
Detailed Description:
The development of depression after a stroke is a serious condition that can have negative effects on thought emotions and overall daily functioning particularly in the first year following the stroke Evidence suggests that antidepressants may be used to prevent post-stroke depression This study will treat nondepressed stroke patients with antidepressants or problem solving therapy PST to determine the most effective treatments for preventing depression
Participants in this study will be randomly assigned to receive PST escitalopram or placebo an inactive pill for 12 months Participants who display depressive symptoms for 2 weeks or more will be removed from the study After 12 months treatment will be discontinued and participants will be monitored for an additional 6 months
Participants in this study will be randomly assigned to receive PST escitalopram or placebo an inactive pill for 12 months Participants who display depressive symptoms for 2 weeks or more will be removed from the study After 12 months treatment will be discontinued and participants will be monitored for an additional 6 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| DATR A4-GPX | US NIH GrantContract | None | httpsreporternihgovquickSearchR01MH065134 |
| R01MH065134 | NIH | None | None |